Verde Bio Holdings, Inc. income statement APHD

It recorded a net loss of $1.5 million. Diluted earnings per share were $0.00.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the same quarter a year earlier.

Line
TTM
Jan 31, 2021
Q3 FY2024
Jan 31, 2024
Q2 FY2024
Oct 31, 2023
Q1 FY2024
Jul 31, 2023
Q4 FY2023
Apr 30, 2023
Q3 FY2023
Jan 31, 2023
Q2 FY2023
Oct 31, 2022
Q1 FY2023
Jul 31, 2022
Q4 FY2022
Apr 30, 2022
Selling, general and administrative
—
0
—
—
—
—
—
—
—
Operating income
-1
-365.0%
-0
+0.9%
-0
-142.1%
-0
+53.2%
-0
+4.4%
-0
+7.1%
-0
+92.2%
-1
-3.1%
-0
+82.7%
Other non-operating income (expense)
—
-1
—
—
—
—
—
—
—
Pretax income
—
-1
—
—
—
—
—
—
—
Net income
—
-1
-239.5%
-0
-127.3%
-0
+57.2%
-1
-21.2%
-0
+39.4%
-0
-1
-0
Net income to common
—
-2
—
—
—
—
—
—
—
Basic EPS
—
0.00
—
—
—
—
—
—
—
Diluted EPS
—
0.00
—
—
—
—
—
—
—
Weighted average shares, basic
—
1,857
—
—
—
—
—
—
—
Weighted average shares, diluted
—
1,857
—
—
—
—
—
—
—
Other measures
Depreciation and amortization
—
0
-0.0%
0
+0.0%
0
+2.3%
0
0
0
0
—
EBITDA
—
-0
+0.9%
-0
-162.2%
-0
+54.4%
-0
-0
-0
-1
—
Interest coverage
-1.91x
—
-28.00x
-449.11x
-15.39x
-42.70x
-46.12x
-25.54x
—
How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

Company profile

Industry
Crude Petroleum & Natural Gas (SIC 1311)
Listed as
APHD (OTC)
Fiscal year ends
April 30
Incorporated in
NV
Headquarters
Frisco, TX
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1490054
Former names
APPIPHANY TECHNOLOGIES HOLDINGS CORP (until Aug 20, 2020)

Other Crude Petroleum & Natural Gas companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.